Citations

Mayo Clinic

Showing 10 of 108551 citations.

Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome
Rodríguez‐Porcel, Federico , Lowder, Lindsey , Rademakers, Rosa , Ravenscroft, Thomas A. , Hagen, Mathew C., Ravenscroft, Thomas, Ghetti, Bernardino , Espay, Alberto J.

Neurology | February 13, 2016 | Volume: 86 | Issue: 12 | Pages: 1164-1166

10.1212/wnl.0000000000002491 | PMID 26873956 Get It

Inheriting a Jewel: A Thrilling Challenge
Bruix, Jordi , Gores, Gregory, Bruix, Jordi

Seminars in Liver Disease | February 12, 2016 | Volume: 36 | Issue: 01 | Pages: 003-004

10.1055/s-0036-1572319 | PMID 26870927 Get It

Therapeutic Strategies for the Treatment of Alcoholic Hepatitis
Singal, Ashwani K. , Shah, Vijay H.

Seminars in Liver Disease | February 12, 2016 | Volume: 36 | Issue: 01 | Pages: 056-068

10.1055/s-0036-1571297 | PMID 26870933 Get It

BEST TEST with MEDIOCRE RESULTS (at best!): a “call to arms” to correct clinician knowledge deficits in transfusion medicine
Stubbs, James R. , Kreuter, Justin D.

Transfusion | February 12, 2016 | Volume: 56 | Issue: 2 | Pages: 285-289

10.1111/trf.13456 | PMID 26864979 Get It

Primary Pseudomyogenic Hemangioendothelioma of Bone
Inyang, Alero F., Mertens, Fredrik , Puls, Florian , Vaiyapuri, Sumathi , Inwards, Carrie Y., Folpe, Andrew L. , Zhang, Yaxia , Symmans, Pennie, Nielsen, G. Petur , Nguyễn, Văn Hùng , Rosenberg, Andrew E. , Inyang, Alero, Lee, Cheng‐Han , Rubin, Brian P.

American Journal of Surgical Pathology | February 12, 2016 | Volume: 40 | Issue: 5 | Pages: 587-598

10.1097/pas.0000000000000613 | PMID 26872012 Get It

Pseudomyogenic hemangioendothelioma (PMH) is a well-recognized neoplasm that usually arises in the soft tissue; concurrent bone involvement occurs in 24% of cases. PMH of bone without soft tissue involvement is rare. We describe the clinicopathologic findings of 10 such cases, the largest series reported to date. The study included 9 male and 1 female patient; their ages ranged from 12 to 74 years (mean 36.7 y). All patients had multiple tumors with a distinct regional distribution: 45% restricted to the lower extremity; 25% to the spine and pelvis; and 15% to the upper extremity. On imaging studies the tumors were well circumscribed and lytic. The neoplasms were composed of spindled cells arranged in intersecting fascicles with scattered epithelioid cells; epithelioid cells predominated in 3 cases. The neoplastic cells contained abundant densely eosinophilic cytoplasm and vesicular nuclei. There was limited cytologic atypia and necrosis, few mitoses (0 to 2/10 high-power fields), and inconspicuous stroma. Unique findings included abundant intratumoral reactive woven bone and hemorrhage with numerous osteoclast-like giant cells. Immunohistochemically, most tumors were positive for keratin, ERG, and CD31; CD34 was negative. The balanced t(7:19)(q22;13) translocation was documented in 3 cases. Follow-up is limited, but no patient developed documented visceral dissemination, and all have stable or progressive osseous disease. PMH exclusively involving bone is rare. It is multicentric, often involves the lower extremity, and has unusual morphology. The differential diagnosis includes epithelioid vascular neoplasms, giant cell tumor, bone forming neoplasms, and metastatic carcinoma. Because of its rarity, unusual presentation, and morphology, accurate diagnosis can be challenging.
The phenotypic legacy of admixture between modern humans and Neandertals
Simonti, Corinne , Vernot, Benjamin , Bastarache, Lisa , Böttinger, Erwin P. , Chisholm, Rex L. , Crosslin, David R. , Hebbring, Scott J. , Jarvik, Gail P. , Li, Rongling, Pathak, Jyotishman , Ritchie, Marylyn D. , Roden, Dan M. , Tromp, Gerard , Prato, Jeffrey D., Bush, William S. , Akey, Joshua M. , Denny, Joshua C. , Capra, John A. , Carrell, David , Kullo, Iftikhar J. , Roden, Dan M. , Verma, Shefali S. , Denny, Joshua C , Jarvik, Gail P , Bush, William S

Science | February 12, 2016 | Volume: 351 | Issue: 6274 | Pages: 737-741

10.1126/science.aad2149 | PMID 26912863 Get It

The legacy of human-Neandertal interbreeding Non-African humans are estimated to have inherited on average 1.5 to 4% of their genomes from Neandertals. However, how this genetic legacy affects human traits is unknown. Simonti et al. combined genotyping data with electronic health records. Individual Neandertal alleles were correlated with clinically relevant phenotypes in individuals of European descent. These archaic genetic variants were associated with medical conditions affecting the skin, the blood, and the risk of depression. Science , this issue p. 737
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease
Northcote, Peter T., Kanakkanthara, Arun , Miller, John H.

Natural Product Reports | February 12, 2016 | Volume: 33 | Issue: 4 | Pages: 549-561

10.1039/c5np00146c | PMID 26867978 Get It

Peloruside A, a microtubule-stabilizing agent isolated from a marine sponge, is a potential therapeutic candidate for the treatment of cancer, neurodegeneration, and autoimmune disease.
Where Do Programmed Death-1 Inhibitors Fit in the Management of Malignant Lymphoma?
Ansell, Stephen M.

Journal of Oncology Practice | February 12, 2016 | Volume: 12 | Issue: 2 | Pages: 101-106

10.1200/jop.2015.009191 | PMID 26869644 Get It

Tumor-specific cytotoxic T cells have the capacity to target and eradicate malignant B cells in patients with Hodgkin and non-Hodgkin lymphoma; however, multiple mechanisms, including regulatory T cells, immunosuppressive ligands, and immune exhaustion, suppress an effective antitumor immune response. One mechanism that is used by malignant cells to inhibit the immune response is overexpression of programmed death ligand 1 or 2 (PD-L1 or PD-L2) on the cancer cell surface. These ligands interact with the programmed death-1 (PD-1) receptor expressed on intratumoral T cells and provide an inhibitory signal, thereby suppressing the antitumor immune response. Monoclonal antibodies that block PD-1 signaling prevent T-cell inhibition and promote a T-cell–mediated antilymphoma response. Blocking antibodies that are directed against PD-1 or PD-L1 are currently being tested in patients with lymphoma and have shown remarkable efficacy, particularly in patients with relapsed Hodgkin lymphoma. On the basis of the promising activity of this approach, PD-1 inhibitors are being used as single-agent therapy in patients with relapsed Hodgkin lymphoma, and these inhibitors are also being tested in combination with standard chemotherapy or targeted agents in ongoing clinical trials.
Agaro-oligosaccharides: a new frontier in the fight against colon cancer?
Bhattarai, Yogesh , Kashyap, Purna

American Journal of Physiology-Gastrointestinal and Liver Physiology | February 12, 2016 | Volume: 310 | Issue: 6 | Pages: G335-G336

10.1152/ajpgi.00049.2016 | PMID 26867562 Get It

Safety and Outcomes of Percutaneous Biopsy of 61 Hepatic Adenomas
Doolittle, Derrick A. , Atwell, Thomas D. , Sánchez, William , Mounajjed, Taofic, Hough, David M., Schmit, Grant D. , Kurup, A. Nicholas , Sanchez, William

American Journal of Roentgenology | February 12, 2016 | Volume: 206 | Issue: 4 | Pages: 871-876

10.2214/ajr.15.15301 | PMID 26866339 Get It